Clinical trial
An Open-Label Evaluation of Safety of the IONSYS System [Fentanyl Iontophoretic Transdermal System (40ug) for Management of Acute Post-Operative Pain in Pediatric Patients
NCT00666393 is registered in ClinicalTrials.gov with Alza Corporation, DE, USA as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open-Label Evaluation of Safety of the IONSYS System [Fentanyl Iontophoretic Transdermal System (40ug) for Management of Acute Post-Operative Pain in Pediatric Patients
- Lead sponsor
- Alza Corporation, DE, USA
- Phase
- Phase 3
- Overall status
- Withdrawn
- Start date
- October 31, 2008
- Completion date
- December 31, 2010
- Enrollment
- 0 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
pain, postoperative, pediatrics